Hair cell and neural contributions to the cochlear summating potential.


Journal

Journal of neurophysiology
ISSN: 1522-1598
Titre abrégé: J Neurophysiol
Pays: United States
ID NLM: 0375404

Informations de publication

Date de publication:
01 06 2019
Historique:
pubmed: 4 4 2019
medline: 25 8 2020
entrez: 4 4 2019
Statut: ppublish

Résumé

The cochlear summating potential (SP) to a tone is a baseline shift that persists for the duration of the burst. It is often considered the most enigmatic of cochlear potentials because its magnitude and polarity vary across frequency and level and its origins are uncertain. In this study, we used pharmacology to isolate sources of the SP originating from the gerbil cochlea. Animals either had the full complement of outer and inner hair cells (OHCs and IHCs) and an intact auditory nerve or had systemic treatment with furosemide and kanamycin (FK) to remove the outer hair cells. Responses to tone bursts were recorded from the round window before and after the neurotoxin kainic acid (KA) was applied. IHC responses were then isolated from the post-KA responses in FK animals, neural responses were isolated from the subtraction of post-KA from pre-KA responses in NH animals, and OHC responses were isolated by subtraction of post-KA responses in FK animals from post-KA responses in normal hearing (NH) animals. All three sources contributed to the SP; OHCs with a negative polarity and IHCs and the auditory nerve with positive polarity. Thus the recorded SP in NH animals is a sum of contributions from different sources, contributing to the variety of magnitudes and polarities seen across frequency and intensity. When this information was applied to observations of the SP recorded from the round window in human cochlear implant subjects, a strong neural contribution to the SP was confirmed in humans as well as gerbils.

Identifiants

pubmed: 30943095
doi: 10.1152/jn.00006.2019
pmc: PMC6620691
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2163-2180

Subventions

Organisme : NIDCD NIH HHS
ID : F30 DC015168
Pays : United States

Références

Hear Res. 2002 Nov;173(1-2):134-52
pubmed: 12372642
J Physiol. 1983 May;338:179-206
pubmed: 6875955
J Am Acad Audiol. 2010 Mar;21(3):145-52
pubmed: 20211118
Hear Res. 2003 Feb;176(1-2):42-58
pubmed: 12583880
Acta Otolaryngol. 1986 Mar-Apr;101(3-4):207-16
pubmed: 3705949
Hear Res. 1992 Aug;61(1-2):137-46
pubmed: 1526886
Scand Audiol. 1996;25(4):233-8
pubmed: 8975994
J Physiol. 1996 Nov 1;496 ( Pt 3):639-46
pubmed: 8930832
Neuron. 2011 Jun 23;70(6):1143-54
pubmed: 21689600
Acta Otolaryngol Suppl. 1972;302:1-46
pubmed: 4354496
Otol Neurotol. 2009 Feb;30(2):131-8
pubmed: 19180674
Hear Res. 1998 Jan;115(1-2):184-96
pubmed: 9472747
Int J Otolaryngol. 2012;2012:852714
pubmed: 22319536
Otol Neurotol. 2012 Dec;33(9):1507-15
pubmed: 23047261
J Acoust Soc Am. 1983 Dec;74(6):1742-6
pubmed: 6655132
Hear Res. 1986;21(2):127-33
pubmed: 3700252
Hear Res. 2015 Jul;325:12-26
pubmed: 25783988
J Acoust Soc Am. 1989 Dec;86(6):2167-71
pubmed: 2600307
Otol Neurotol. 2016 Dec;37(10):1654-1661
pubmed: 27749750
Am J Otol. 1988 Jan;9(1):31-8
pubmed: 3364534
Hear Res. 1985;20(3):267-73
pubmed: 3003019
Ear Hear. 2019 May/Jun;40(3):577-591
pubmed: 30169463
J Acoust Soc Am. 1990 Jun;87(6):2621-7
pubmed: 2373796
Front Neurosci. 2017 Oct 23;11:592
pubmed: 29123468
Hear Res. 1992 May;59(2):157-70
pubmed: 1618707
Am J Physiol. 1958 Nov;195(2):251-61
pubmed: 13583157
Hear Res. 1996 May;94(1-2):148-56
pubmed: 8789820
Otol Neurotol. 2015 Mar;36(3):399-405
pubmed: 25473960
Otol Neurotol. 2014 Sep;35(8):1451-7
pubmed: 24892369
Cold Spring Harb Symp Quant Biol. 1965;30:181-90
pubmed: 5219471
Front Syst Neurosci. 2017 Jan 24;11:2
pubmed: 28174524
J Acoust Soc Am. 2008 Apr;123(4):2200-12
pubmed: 18397026
Ear Hear. 1998 Feb;19(1):37-47
pubmed: 9504271
Hear Res. 1995 Aug;88(1-2):27-35
pubmed: 8576000
J Physiol. 1987 Feb;383:551-69
pubmed: 3656135
J Acoust Soc Am. 1965 Jul;38:126-31
pubmed: 14347603
Acta Otolaryngol Suppl. 2009 Feb;(560):38-42
pubmed: 19221905
Hear Res. 1982 Aug;7(3):261-79
pubmed: 7118731
Hear Res. 1997 Nov;113(1-2):76-88
pubmed: 9387987
Hear Res. 1984 Sep;15(3):261-80
pubmed: 6501114
Nature. 1983 Jan 27;301(5898):334-6
pubmed: 6823305
Neuroreport. 2004 Jun 28;15(9):1379-82
pubmed: 15194856
Elife. 2015 Nov 06;4:
pubmed: 26544545
J Physiol. 1990 Feb;421:263-91
pubmed: 2348394
J Acoust Soc Am. 1998 Jul;104(1):370-7
pubmed: 9670530
Acta Otolaryngol. 2010;130(1):95-101
pubmed: 19396716
Ear Hear. 2010 Feb;31(1):7-21
pubmed: 19838117
Hear Res. 1984 Jun;14(3):305-14
pubmed: 6480516
Ear Hear. 2015 Mar-Apr;36(2):249-60
pubmed: 25259669
Front Neurosci. 2017 Jun 16;11:301
pubmed: 28670263
Otol Neurotol. 2016 Feb;37(2):e148-53
pubmed: 26756149
Brain. 1996 Jun;119 ( Pt 3):741-53
pubmed: 8673487
J Neurophysiol. 2014 Feb;111(3):580-93
pubmed: 24133227
Ear Hear. 2018 Nov/Dec;39(6):1146-1156
pubmed: 29554036
Ear Hear. 2010 Jun;31(3):325-35
pubmed: 20090530
J Physiol. 1992 Mar;448:73-98
pubmed: 1593487
J Assoc Res Otolaryngol. 2012 Apr;13(2):209-217
pubmed: 22160753
J Acoust Soc Am. 1969 Jun;45(6):1443-50
pubmed: 5803167
J Neurophysiol. 1978 Mar;41(2):365-83
pubmed: 650272
Biophys J. 1993 Nov;65(5):2217-27
pubmed: 8298045
Hear Res. 1992 Nov;63(1-2):79-89
pubmed: 1464578
Acta Otolaryngol Suppl. 1993;504:58-67
pubmed: 8470535
J Acoust Soc Am. 1976 Aug;60(2):510-2
pubmed: 993471
J Assoc Res Otolaryngol. 2008 Mar;9(1):65-89
pubmed: 18157569
Otol Neurotol. 2014 Oct;35(9):e245-52
pubmed: 25118584
Ear Hear. 1999 Jun;20(3):238-52
pubmed: 10386850
Acta Otolaryngol. 1966 Dec;62(6):465-80
pubmed: 5973119
Otol Neurotol. 2010 Oct;31(8):1233-41
pubmed: 20818290
Proc Natl Acad Sci U S A. 1950 Oct;36(10):580-7
pubmed: 14808143
Ear Hear. 2018 Jul/Aug;39(4):687-700
pubmed: 29251689
Otol Neurotol. 2015 Aug;36(7):1172-80
pubmed: 25839980
J Acoust Soc Am. 2004 Nov;116(5):3022-30
pubmed: 15603147
Front Neurosci. 2017 Jul 19;11:416
pubmed: 28769753
Ear Hear. 2019 Jul/Aug;40(4):833-848
pubmed: 30335669
J Neurosci. 1985 Jun;5(6):1591-608
pubmed: 4009248
Otol Neurotol. 2014 Jan;35(1):64-71
pubmed: 24317211
J Assoc Res Otolaryngol. 2006 Sep;7(3):218-35
pubmed: 16718614
J Am Acad Audiol. 1994 Jan;5(1):24-9
pubmed: 8155891
PLoS One. 2016 Sep 12;11(9):e0162726
pubmed: 27618300

Auteurs

Andrew K Pappa (AK)

Department of Otolaryngology and Head and Neck Surgery, University of North Carolina at Chapel Hill , Chapel Hill, North Carolina.

Kendall A Hutson (KA)

Department of Otolaryngology and Head and Neck Surgery, University of North Carolina at Chapel Hill , Chapel Hill, North Carolina.

William C Scott (WC)

Department of Otolaryngology and Head and Neck Surgery, University of North Carolina at Chapel Hill , Chapel Hill, North Carolina.

J David Wilson (JD)

Department of Otolaryngology and Head and Neck Surgery, University of North Carolina at Chapel Hill , Chapel Hill, North Carolina.

Kevin E Fox (KE)

Campbell University School of Osteopathic Medicine, Lillington, North Carolina.

Maheer M Masood (MM)

Department of Otolaryngology and Head and Neck Surgery, University of North Carolina at Chapel Hill , Chapel Hill, North Carolina.

Christopher K Giardina (CK)

Department of Otolaryngology and Head and Neck Surgery, University of North Carolina at Chapel Hill , Chapel Hill, North Carolina.

Stephen H Pulver (SH)

Department of Otolaryngology and Head and Neck Surgery, University of North Carolina at Chapel Hill , Chapel Hill, North Carolina.

Gilberto D Grana (GD)

Department of Otolaryngology and Head and Neck Surgery, University of North Carolina at Chapel Hill , Chapel Hill, North Carolina.

Charles Askew (C)

Gene Therapy Center, University of North Carolina at Chapel Hill , Chapel Hill, North Carolina.

Douglas C Fitzpatrick (DC)

Department of Otolaryngology and Head and Neck Surgery, University of North Carolina at Chapel Hill , Chapel Hill, North Carolina.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH